1. Zhou, Qingxin, Lin, Meihua, Feng, Xing, Zou, Chang, Zhang, Zhiyong. . Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. In The Journal of experimental medicine, 217, . doi:10.1084/jem.20191779. https://pubmed.ncbi.nlm.nih.gov/32453420/
2. Ma, Yulin, Gao, Fei, Liu, Yang. 2024. CLK3 positively promoted colorectal cancer proliferation by activating IL-6/STAT3 signaling. In Experimental cell research, 440, 114132. doi:10.1016/j.yexcr.2024.114132. https://pubmed.ncbi.nlm.nih.gov/38885806/
3. Virgirinia, Regina Putri, Nakamura, Makoto, Takebayashi-Suzuki, Kimiko, Fatchiyah, Fatchiyah, Suzuki, Atsushi. 2021. The dual-specificity protein kinase Clk3 is essential for Xenopus neural development. In Biochemical and biophysical research communications, 567, 99-105. doi:10.1016/j.bbrc.2021.06.005. https://pubmed.ncbi.nlm.nih.gov/34146908/
4. Li, Hua, Cui, Xichun, Hu, Qiuyue, Chen, Xiaolong, Zhou, Pengli. 2019. CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma. In OncoTargets and therapy, 12, 9201-9213. doi:10.2147/OTT.S224527. https://pubmed.ncbi.nlm.nih.gov/31807004/
5. Cesana, Marcella, Guo, Michael H, Cacchiarelli, Davide, Hirschhorn, Joel N, Daley, George Q. . A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development. In Cell stem cell, 22, 575-588.e7. doi:10.1016/j.stem.2018.03.012. https://pubmed.ncbi.nlm.nih.gov/29625070/
智鼠故事 
